• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Omrix Biopharmaceuticals

edit

Omrix Biopharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets biological products for the biosurgical and immunotherapy markets.

The company, formerly known as Omrix Biopharmaceuticals S.A., was founded in 1995 and is headquartered in New York. As of December 26, 2008, Omrix Biopharmaceuticals, Inc. operates as a subsidiary of Johnson & Johnson.

Recent Milestones

edit

• 
  Omrix Biopharmaceuticals was acquired by Johnson & Johnson for $433M. (11/23/08)
  Posted 9/10/09 at 3:15am via ethicon.com
• 
  Omrix Biopharmaceuticals received $4.84M in Venture Round funding. (3/31/05)
  Posted 8/30/10 at 11:05pm
• 
  Omrix Biopharmaceuticals added Robert Taub as Founder.
  Posted 9/10/09 at 2:52am
• 
  Omrix Biopharmaceuticals added Asaf Alperovitz as CFO.
  Posted 9/10/09 at 2:52am

Videos

Screenshots

edit

Sources

1. Johnson & Johnson Completes Acquisition of Omrix Biopharmaceuticals, Inc. (ethicon.com) [edit]
2. EDGAR [edit]